Share this page

 EMCYLMI — 2507149

Toolbar

Toolbar

Details

Third-party disclaimer

Share this page

No endorsement of any products or services is expressed or implied.

Third-party disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Application number

2507149

Type(s)

Standard Characters

Category

Trademark

CIPO Status

FORMALIZED

TM5 status

LIVE/APPLICATION/ Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.

Filed

2026-10-13

Applicant

Cartesian Therapeutics, Inc.
7495 New Horizon Way, Suite 130
Frederick, MD 21703
UNITED STATES OF AMERICA

Agent

MARKS & CLERK
33 Yonge Street,
Suite 300
Toronto
ONTARIO M5E1G4

Documents

View documents

Index headings

  • EMCYLMI

Goods (Nice class & Statement)

5
(1) Pharmaceutical preparations for the treatment of autoimmune diseases

Claims

  • Priority Filing Date: April 14, 2026, Country or Office: UNITED STATES OF AMERICA, Application No. 99763432 in association with the same kind of goods

Action History

Actions
Action Action date Due date Comments
Filed 2026-10-13
Created 2026-10-13
Formalized 2026-10-13
Report a problem on this page
Date modified: